ArticleBioinformatics (Oxford, England)2025
Cancer survival prediction based on soft-label guided contrastive learning and global feature fusion.
Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
motivationThe high complexity and heterogeneity of cancer pose significant challenges to personalized treatment, making the improvement of cancer survival prediction accuracy crucial for clinical decision-making. The integration of multi-omics data enables a more comprehensive capture of multi-layered information in complex biological processes. However, existing survival analysis models still face limitations in accurately extracting and effectively integrating the unique and shared information from multi-omics data.
resultsIn this article, we propose a novel prediction model for cancer survival based on soft-label guided contrastive learning and global feature fusion, namely SLCGF. Our model first extracts paired feature representations for each omics using Siamese encoders. We then perform intra-view and inter-view contrastive learning simultaneously, employing a neighborhood-based paradigm to enhance feature discrimination and alignment across omics. To ensure reliable neighbor retention and improve model robustness, we treat the affinities between samples and their high-order neighbors as soft labels to guide the contrastive learning process at both levels. In addition, we adopt a global self-attention mechanism to obtain the unified representation for cancer survival prediction, where the cross-omics connections are fully exploited and complementary information is adaptively integrated. We comprehensively evaluate the performance of our model on 13 cancer multi-omics datasets, and the experimental results demonstrate its superiority over existing approaches. AVAILABILITY AND IMPLEMENTATION: Source code is available at https://github.com/LiangSDNULab/SLCGF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.